CASI Pharmaceuticals (CASIF) Prepaid Assets (2021 - 2025)
CASI Pharmaceuticals (CASIF) reported Prepaid Assets of $2.1 million for Q4 2025, down 26.07% on a YoY basis from $2.9 million in Q4 2024, and up 6.22% quarter-over-quarter from $2.0 million in Q3 2025.
CASI Pharmaceuticals (CASIF) Prepaid Assets (2021 - 2025) Analysis & Trends
CASI Pharmaceuticals has reported Prepaid Assets for 5 years, with the latest figure at $2.1 million in Q4 2025.
- For the quarter ending Q4 2025, Prepaid Assets fell 26.07% year-over-year to $2.1 million; the trailing twelve-month figure through Dec 2025 stood at $2.1 million (down 26.07% YoY), and the FY2025 full-year result was $2.1 million, down 26.07% from the prior year.
- Prepaid Assets for Q4 2025 stood at $2.1 million, up from $2.0 million in the prior quarter.
- The five-year high for Prepaid Assets was $2.7 billion in Q1 2025, with the low at $1.7 million in Q4 2021.
- Historically, Prepaid Assets has averaged $846.7 million across 5 years, with a median of $2.9 million in 2024.
- Annual changes were most pronounced in 2024 — Prepaid Assets tumbled 99.89% — and 2025, when it jumped 135229.34%.
- CASI Pharmaceuticals' Prepaid Assets stood at $1.7 million in 2021, then jumped by 76.24% to $3.0 million in 2022, then jumped by 85950.42% to $2.6 billion in 2023, then plunged by 99.89% to $2.9 million in 2024, then dropped by 26.07% to $2.1 million in 2025.
- The last three Prepaid Assets figures came in at $2.1 million (Q4 2025), $2.0 million (Q3 2025), and $2.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 860,679.92 Bn | 860,679.89 Bn | - |
| 2 | Belite Bio | 55,284.00 Bn | 55,284.00 Bn | - |
| 3 | Quantum Biopharma | 16,206.94 Bn | 16,206.93 Bn | - |
| 4 | Legend Biotech | 3,318.00 Bn | 3,317.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,543.84 Bn | 1,543.84 Bn | - |
| 6 | Evaxion A | 1,449.11 Bn | 1,449.09 Bn | - |
| 7 | Psyence Biomedical | 216.99 Bn | 216.98 Bn | - |
| 8 | Vertex Pharmaceuticals | 115.22 Bn | 107.97 Bn | 2.59 Bn |
| 9 | Abivax | 90.58 Bn | 90.58 Bn | - |
| 10 | CASI Pharmaceuticals | - | - | 3.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.14 Mn |
| Sep 30, 2025 | 2.01 Mn |
| Jun 30, 2025 | 2.64 Mn |
| Mar 31, 2025 | 2.71 Bn |
| Dec 31, 2024 | 2.89 Mn |
| Jun 30, 2024 | 2.11 Bn |
| Mar 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | 2.56 Bn |
| Jun 30, 2023 | 1.91 Bn |
| Dec 31, 2022 | 2.98 Mn |
| Dec 31, 2021 | 1.69 Mn |